MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2012

Sep 17, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNTA PHARMACEUTICALS CORP (SNTA)
CIK: 0001157601
Period of Report: 2012-09-13

Reporting Person: Singh Amar (Sr. VP, Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-13	Employee Stock Option (Right to Buy)	$8.05	A	25000	Acquired	2022-09-13	Common Stock (25000)	Direct

Footnotes

F1: The option vests as to 25% of the shares on September 13, 2013 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.